Composition containing titanium dioxide nanotubes and application of composition in preparation of products for promoting osteogenesis maturation of osteoblasts

By modifying the titanium dioxide nanotubes, a synergistic composition is formed, which solves the problems of poor maturation effect and low antibacterial performance in the prior art, and has achieved significant improvement in osteogenic differentiation and antibacterial performance. Effects provide new solutions for biomedical materials.

CN119033999APending Publication Date: 2024-11-29许隽松
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411026255.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing titanium dioxide nanotubes have poor effect in promoting osteoblast maturation and have low antibacterial properties, making it difficult to meet the needs of biomedical materials.

Method used

By combining modified titanium dioxide nanotube A and modified titanium dioxide nanotube B, a synergistic effect is formed by modifying dopamine hydrochloride, osteogenic growth peptide, cyclodextrin, curcumin, aloe emodin and cassin, etc. The composition enhances its osteogenic differentiation and antibacterial properties.

Benefits of technology

It significantly improves the effect of promoting osteoblast maturation and significantly improves antibacterial properties, making it of important application value in biomedical materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention provides a composition containing titanium dioxide nanotubes and application of the composition in preparation of a product for promoting osteogenesis maturation of osteoblasts, and the composition containing the titanium dioxide nanotubes comprises a modified titanium dioxide nanotube A and a modified titanium dioxide nanotube B in a mass ratio of (2-3): 1, the two modified titanium dioxide nanotubes are compounded for use, the synergistic interaction effect can be achieved, the effect of promoting osteoblast osteogenesis maturation can be remarkably improved, ossification growth peptide is fixed to the surfaces of the titanium dioxide nanotubes through polydopamine, the ossification growth peptide and curcumin, aloe-emodin and obtusin modified titanium dioxide nanotubes are fixed to the surfaces of the titanium dioxide nanotubes through polydopamine, and the effect of promoting osteoblast osteogenesis maturation is achieved. The synergistic effect can directly promote osteogenic differentiation, and meanwhile, the antibacterial property is improved, so that the material has important significance in development of important biomedical materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomedical materials, and specifically relates to a composition containing titanium dioxide nanotubes and an application of the composition in preparing a product for promoting osteoblast maturation. Background Art

[0002] Nanotechnology is increasingly being used in the field of medical devices. At present, there have been some reports on improving the antibacterial ability of materials, such as using antibiotics and other antibacterial molecules to improve the antibacterial effect of titanium. With the development of society, the use of medical materials, especially implants, has increased, and the related bacterial infection problems have received more and more attention. Compared with titanium metal, titanium dioxide nanotubes have the effect of promoting osteoblastogenesis and have shown great potential and advantages in the application of implants.

[0003] With the rapid development of nanotechnology, titanium dioxide nanotubes have attracted widespread attention as a nanomaterial with unique properties and wide application potential. Titanium dioxide nanotubes have good biocompatibility and can be used in drug delivery, tissue engineering and other applications in the biomedical field. As a nanomaterial with multiple excellent properties, titanium dioxide nanotubes have a wide range of application potential. Titanium dioxide nanotubes have broad application prospects in the fields of solar cells, catalysts, sensors, energy storage materials and biomedicine. Titanium dioxide materials are commonly used in medical applications and devices, including implants, facial cosmetic surgery, cardiovascular devices, external prostheses, and surgical instruments. When approaching nanometer size, titanium dioxide materials are quantum confined on ultrafine sheets and introduce new physical, mechanical, optical and electronic properties. Compared with traditional bulk materials, titanium dioxide nanostructures are widely used in cutting-edge biomedical fields with different morphologies (such as spheres, tubes, cylinders, fibers, sheets, whiskers, wires and rods) through feasible and reproducible preparation strategies. Titanium dioxide nanostructures exhibit a wide range of diagnostic and therapeutic properties, making their application in biomedicine very attractive. Titanium dioxide nanostructures are expected to improve current theoretical strategies by taking advantage of enhanced quantum confinement, thermal conversion, specific surface area, and surface activity.

[0004] However, the existing titanium dioxide nanotubes are not ideal for promoting osteoblast maturation, and have low antibacterial properties and poor use effects.

[0005] Curcumin is a yellow pigment extracted from the rhizome of turmeric. It is the main curcuminoid substance, accounting for about 70% of curcuminoids and about 3% to 6% of turmeric. Chemically speaking, curcumin is diarylheptanoic acid, a curcuminoid compound, and a natural phenol that causes the yellow color of turmeric. It is a tautomeric compound that exists in the enol form in organic solvents and in the ketone form in water.

[0006] Dopamine hydrochloride is a crystalline white powder. After the effects of dopamine hydrochloride were discovered in clinical medicine, dopamine hydrochloride has been widely used in medicine. Dopamine hydrochloride injection is suitable for shock syndrome caused by myocardial infarction, trauma, endotoxin sepsis, heart surgery, renal failure, congestive heart failure, etc. Common symptoms include chest pain, dyspnea, palpitations, arrhythmia, and general weakness; slow heartbeat, headache, nausea and vomiting are rare.

[0007] Cyclodextrin (CD) is a general term for a series of cyclic oligosaccharides produced by amylose under the action of cyclodextrin glucosyltransferase produced by Bacillus, usually containing 6 to 12 D-pyranose units. Among them, the molecules containing 6, 7, and 8 glucose units are studied more and have important practical significance, which are called alpha-, beta- and gama-cyclodextrins respectively. According to the results of X-ray crystal diffraction, infrared spectroscopy and nuclear magnetic resonance spectroscopy analysis, it is determined that each D(+)-pyranose glucose constituting the cyclodextrin molecule is in a chair conformation. Each glucose unit is linked to a ring by a 1,4-glycosidic bond. Since the glycosidic bonds connecting the glucose units cannot rotate freely, cyclodextrin is not a cylindrical molecule but a slightly conical ring. Among them, the primary hydroxyl groups of cyclodextrin surround the small mouth of the cone, while its secondary hydroxyl groups surround the large mouth of the cone.

[0008] Since the rim of cyclodextrin is hydrophilic and the cavity is hydrophobic, it can provide a hydrophobic binding site like an enzyme, and act as a host to encapsulate various appropriate guests, such as organic molecules, inorganic ions, and gas molecules. Its hydrophobic inner cavity and hydrophilic outer properties enable it to form inclusion compounds and molecular assembly systems with many organic and inorganic molecules based on van der Waals forces, hydrophobic interactions, and matching effects between host and guest molecules, making it an interesting research object for chemistry and chemical researchers. This selective encapsulation effect is commonly known as molecular recognition, and the result is the formation of a host-guest complex. Cyclodextrin is the ideal host molecule similar to an enzyme discovered so far, and it itself has the characteristics of an enzyme model. Therefore, in the fields of catalysis, separation, food, and medicine, cyclodextrin has received great attention and is widely used. Due to the solubility and inclusion capacity of cyclodextrin in water, changing the physical and chemical properties of cyclodextrin has become one of the important purposes of chemical modification of cyclodextrin. Summary of the invention

[0009] The purpose of the present invention is to provide a composition containing titanium dioxide nanotubes and application thereof in preparing a product for promoting osteoblast maturation.

[0010] In order to achieve the above object, the present invention provides the following technical solutions: A composition containing titanium dioxide nanotubes, the composition comprising modified titanium dioxide nanotubes A and modified titanium dioxide nanotubes B in a mass ratio of 2-3:1; The preparation method of the modified titanium dioxide nanotube A comprises the following steps: (1) immersing 1 part by weight of titanium dioxide nanotube A in 10-12 parts by weight of dopamine hydrochloride solution, reacting at 20-40° C. for 10-30 hours, filtering, washing with water for 3-5 times, and drying at 25-40° C. to obtain polydopamine-modified titanium dioxide nanotubes; (2) Immerse 1 part by mass of polydopamine-modified titanium dioxide nanotubes in 6-8 parts by mass of osteogenic growth peptide solution, react at 20-40° C. for 10-30 hours, filter, wash with phosphate buffer solution for 3-5 times, and dry at 25-40° C. to obtain modified titanium dioxide nanotubes A.

[0011] The preparation method of the modified titanium dioxide nanotube B comprises the following steps: (a) mixing cyclodextrin, water and titanium dioxide nanotubes B in a mass ratio of 0.2-0.5:5-8:1, and soaking at 52-55° C. for 80-100 min to obtain a mixture; (b) The mixture with a mass ratio of 10-12:1:0.3:0.5, curcumin, aloe-emodin and cassia bark were mixed, sonicated, filtered and dried to obtain modified titanium dioxide nanotubes B.

[0012] Furthermore, in the step (a), the cyclodextrin is β-cyclodextrin.

[0013] Furthermore, the mixing conditions in step (b) are stirring at 200-500 rpm for 30-100 min, the drying method is drying in a rotary kiln, the rotary kiln has a diameter of 100-300 mm, an effective working length of 1000-2000 mm, a drying temperature of 150°C-200°C, and an inert gas flow rate of 5-8 L / min; and the ultrasonic conditions are: 20-25 kHz ultrasonic wave for 80-100 min.

[0014] Furthermore, in step (a), the titanium dioxide nanotubes B have a diameter of 10-15 nm and a length of 1-5 μm.

[0015] Furthermore, the preparation method of the dopamine hydrochloride solution in step (1) is: dissolving dopamine hydrochloride in 8-10 mmol / L tris(hydroxymethyl)aminomethane buffer to prepare a dopamine hydrochloride solution with a concentration of 1-3 mg / mL.

[0016] Furthermore, in step (1), the pH of the dopamine hydrochloride solution is adjusted to 8.5.

[0017] Furthermore, the preparation method of the osteogenic growth peptide solution in step (2) is: dissolving the osteogenic growth peptide in 11-14 mmol / L tris(hydroxymethyl)aminomethane buffer to prepare an osteogenic growth peptide solution with a concentration of 12-14 ng / mL.

[0018] Furthermore, in step (1), the diameter of the titanium dioxide nanotube A is 20-25 nm, and the length is 5-10 μm.

[0019] Osteogenic Growth Peptide, CAS No.: 132996-61-3. Curcumin, CAS No.: 458-37-7.

[0020] Aloe-emodin, CAS: 481-72-1.

[0021] Cassiae, Cassiae, also known as 1,7-dihydroxy-2,3,8-trimethoxy-6-methylanthracene-9,10-dione, has a molecular formula of C 18 H 16 O7, molecular weight is 344.31.

[0022] The present invention also provides the use of the composition containing titanium dioxide nanotubes in preparing a product for promoting osteoblast maturation.

[0023] Furthermore, the composition containing titanium dioxide nanotubes is used in the preparation of medical titanium materials.

[0024] Compared with the prior art, the advantages and beneficial effects of the present invention are as follows: the present invention provides a composition containing titanium dioxide nanotubes and its application in the preparation of a product for promoting osteoblast maturation. The present invention can play a synergistic role by compounding two modified titanium dioxide nanotubes, and can significantly improve the effect of promoting osteoblast maturation. Among them, polydopamine fixes osteogenic growth peptides on the surface of titanium dioxide nanotubes, and synergizes with natural products curcumin, aloe-emodin, and cassia to modify the titanium dioxide nanotubes, which can directly promote osteogenic differentiation and improve the antibacterial properties, which is of great significance for the development of important biomedical materials. DETAILED DESCRIPTION

[0025] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0026] Example 1 This embodiment provides a composition containing titanium dioxide nanotubes, the composition comprising modified titanium dioxide nanotubes A and modified titanium dioxide nanotubes B in a mass ratio of 2.5:1; The preparation method of the modified titanium dioxide nanotube A comprises the following steps: (1) immersing 1 part by weight of titanium dioxide nanotube A in 11 parts by weight of dopamine hydrochloride solution, reacting at 27° C. for 18 h, filtering, washing with water 4 times, and drying at 27° C. to obtain polydopamine-modified titanium dioxide nanotubes; (2) Immerse 1 part by mass of polydopamine-modified titanium dioxide nanotubes in 7 parts by mass of osteogenic growth peptide solution, react at 27° C. for 18 h, filter, wash 4 times with phosphate buffer solution, and dry at 27° C. to obtain modified titanium dioxide nanotubes A.

[0027] The preparation method of the modified titanium dioxide nanotube B comprises the following steps: (a) Cyclodextrin, water and titanium dioxide nanotubes B in a mass ratio of 0.4:7:1 were mixed and immersed at 54° C. for 90 min to obtain a mixture; (b) A mixture with a mass ratio of 11:1:0.3:0.5, curcumin, aloe-emodin and cassia bark were mixed, sonicated, filtered and dried to obtain modified titanium dioxide nanotubes B.

[0028] The cyclodextrin in step (a) is β-cyclodextrin.

[0029] The mixing conditions in step (b) are stirring at 300 rpm for 70 min, the drying method is drying in a rotary kiln, the rotary kiln has a diameter of 200 mm, an effective working length of 2000 mm, a drying temperature of 180° C., and an inert gas flow rate of 7 L / min; the ultrasonic conditions are: 22 kHz ultrasonic wave for 90 min.

[0030] In the step (a), the titanium dioxide nanotubes B have a diameter of 10-15 nm and a length of 1-5 μm.

[0031] The preparation method of the dopamine hydrochloride solution in step (1) is as follows: dissolving dopamine hydrochloride in 9 mmol / L tris(hydroxymethyl)aminomethane buffer to obtain a dopamine hydrochloride solution with a concentration of 2 mg / mL.

[0032] In the step (1), the pH of the dopamine hydrochloride solution is adjusted to 8.5.

[0033] The preparation method of the osteogenic growth peptide solution in step (2) is: dissolving the osteogenic growth peptide in 13 mmol / L tris(hydroxymethylaminomethane) buffer to prepare an osteogenic growth peptide solution with a concentration of 13 ng / mL.

[0034] In the step (1), the diameter of the titanium dioxide nanotube A is 20-25 nm and the length is 5-10 μm.

[0035] Osteogenic Growth Peptide, CAS No.: 132996-61-3. Curcumin, CAS No.: 458-37-7.

[0036] Example 2 This embodiment provides a composition containing titanium dioxide nanotubes, the composition comprising modified titanium dioxide nanotubes A and modified titanium dioxide nanotubes B in a mass ratio of 2:1; The preparation method of the modified titanium dioxide nanotube A comprises the following steps: (1) immersing 1 part by weight of titanium dioxide nanotube A in 10 parts by weight of dopamine hydrochloride solution, reacting at 25° C. for 15 h, filtering, washing with water three times, and drying at 25° C. to obtain polydopamine-modified titanium dioxide nanotubes; (2) Immerse 1 part by mass of polydopamine-modified titanium dioxide nanotubes in 6 parts by mass of osteogenic growth peptide solution, react at 25° C. for 15 h, filter, wash three times with phosphate buffer solution, and dry at 25° C. to obtain modified titanium dioxide nanotubes A.

[0037] The preparation method of the modified titanium dioxide nanotube B comprises the following steps: (a) Cyclodextrin, water and titanium dioxide nanotubes B in a mass ratio of 0.2:5:1 were mixed and immersed at 52° C. for 80 min to obtain a mixture; (b) A mixture with a mass ratio of 10:1:0.3:0.5, curcumin, aloe-emodin and cassia bark were mixed, sonicated, filtered and dried to obtain modified titanium dioxide nanotubes B.

[0038] The cyclodextrin in step (a) is β-cyclodextrin.

[0039] The mixing conditions in step (b) are stirring at 200 rpm for 30 min, the drying method is drying in a rotary kiln with a diameter of 100 mm, an effective working length of 1000 mm, a drying temperature of 150° C., and an inert gas flow rate of 5 L / min; the ultrasonic conditions are: 20 kHz ultrasonic wave for 80 min. The diameter of the titanium dioxide nanotube B in step (a) is 10-15 nm, and the length is 1-5 μm.

[0040] The preparation method of the dopamine hydrochloride solution in step (1) is as follows: dissolving dopamine hydrochloride in 8 mmol / L tris(hydroxymethyl)aminomethane buffer to obtain a dopamine hydrochloride solution with a concentration of 1 mg / mL.

[0041] In the step (1), the pH of the dopamine hydrochloride solution is adjusted to 8.5.

[0042] The preparation method of the osteogenic growth peptide solution in step (2) is: dissolving the osteogenic growth peptide in 11 mmol / L tris(hydroxymethyl)aminomethane buffer to prepare an osteogenic growth peptide solution with a concentration of 12 ng / mL.

[0043] In the step (1), the diameter of the titanium dioxide nanotube A is 20-25 nm and the length is 5-10 μm.

[0044] Osteogenic Growth Peptide, CAS No.: 132996-61-3. Curcumin, CAS No.: 458-37-7.

[0045] Example 3 This embodiment provides a composition containing titanium dioxide nanotubes, the composition comprising modified titanium dioxide nanotubes A and modified titanium dioxide nanotubes B in a mass ratio of 3:1; The preparation method of the modified titanium dioxide nanotube A comprises the following steps: (1) immersing 1 part by weight of titanium dioxide nanotube A in 12 parts by weight of dopamine hydrochloride solution, reacting at 30° C. for 20 hours, filtering, washing with water for 5 times, and drying at 30° C. to obtain polydopamine-modified titanium dioxide nanotubes; (2) 1 part by weight of polydopamine-modified titanium dioxide nanotubes was immersed in 8 parts by weight of osteogenic growth peptide solution, reacted at 30° C. for 20 h, filtered, washed 5 times with phosphate buffer solution, and dried at 30° C. to obtain modified titanium dioxide nanotubes A.

[0046] The preparation method of the modified titanium dioxide nanotube B comprises the following steps: (a) mixing cyclodextrin, water and titanium dioxide nanotubes B in a mass ratio of 0.5:8:1, and soaking them at 55°C for 100 minutes to obtain a mixture; (b) A mixture with a mass ratio of 12:1:0.3:0.5, curcumin, aloe-emodin and cassia bark were mixed, sonicated, filtered and dried to obtain modified titanium dioxide nanotubes B.

[0047] The cyclodextrin in step (a) is β-cyclodextrin.

[0048] The mixing conditions in step (b) are stirring at 500 rpm for 100 min, the drying method is drying in a rotary kiln with a diameter of 300 mm, an effective working length of 2000 mm, a drying temperature of 200° C., and an inert gas flow rate of 8 L / min; and the ultrasonic conditions are: 25 kHz ultrasonic wave for 100 min.

[0049] In the step (a), the titanium dioxide nanotubes B have a diameter of 10-15 nm and a length of 1-5 μm.

[0050] The preparation method of the dopamine hydrochloride solution in step (1) is as follows: dissolving dopamine hydrochloride in 10 mmol / L tris(hydroxymethyl)aminomethane buffer to obtain a dopamine hydrochloride solution with a concentration of 3 mg / mL.

[0051] In the step (1), the pH of the dopamine hydrochloride solution is adjusted to 8.5.

[0052] The preparation method of the osteogenic growth peptide solution in step (2) is: dissolving the osteogenic growth peptide in 14 mmol / L tris(hydroxymethyl)aminomethane buffer to prepare an osteogenic growth peptide solution with a concentration of 14 ng / mL.

[0053] In the step (1), the diameter of the titanium dioxide nanotube A is 20-25 nm and the length is 5-10 μm.

[0054] Osteogenic Growth Peptide, CAS No.: 132996-61-3. Curcumin, CAS No.: 458-37-7.

[0055] Comparative Example 1 The difference between this comparative example and Example 1 is that the ratio of the modified titanium dioxide nanotube A to the modified titanium dioxide nanotube B is different.

[0056] A composition containing titanium dioxide nanotubes, the composition comprising modified titanium dioxide nanotubes A and modified titanium dioxide nanotubes B in a mass ratio of 1:2.5; The preparation method of the modified titanium dioxide nanotube A comprises the following steps: (1) immersing 1 part by weight of titanium dioxide nanotube A in 11 parts by weight of dopamine hydrochloride solution, reacting at 27° C. for 18 h, filtering, washing with water 4 times, and drying at 27° C. to obtain polydopamine-modified titanium dioxide nanotubes; (2) Immerse 1 part by mass of polydopamine-modified titanium dioxide nanotubes in 7 parts by mass of osteogenic growth peptide solution, react at 27° C. for 18 h, filter, wash 4 times with phosphate buffer solution, and dry at 27° C. to obtain modified titanium dioxide nanotubes A.

[0057] The preparation method of the modified titanium dioxide nanotube B comprises the following steps: (a) Cyclodextrin, water and titanium dioxide nanotubes B in a mass ratio of 0.4:7:1 were mixed and immersed at 54° C. for 90 min to obtain a mixture; (b) A mixture with a mass ratio of 11:1:0.3:0.5, curcumin, aloe-emodin and cassia bark were mixed, sonicated, filtered and dried to obtain modified titanium dioxide nanotubes B.

[0058] The cyclodextrin in step (a) is β-cyclodextrin.

[0059] The mixing conditions in step (b) are stirring at 300 rpm for 70 min, the drying method is drying in a rotary kiln, the rotary kiln has a diameter of 200 mm, an effective working length of 2000 mm, a drying temperature of 180° C., and an inert gas flow rate of 7 L / min; the ultrasonic conditions are: 22 kHz ultrasonic wave for 90 min.

[0060] In the step (a), the titanium dioxide nanotubes B have a diameter of 10-15 nm and a length of 1-5 μm.

[0061] The preparation method of the dopamine hydrochloride solution in step (1) is as follows: dissolving dopamine hydrochloride in 9 mmol / L tris(hydroxymethyl)aminomethane buffer to obtain a dopamine hydrochloride solution with a concentration of 2 mg / mL.

[0062] In the step (1), the pH of the dopamine hydrochloride solution is adjusted to 8.5.

[0063] The preparation method of the osteogenic growth peptide solution in step (2) is: dissolving the osteogenic growth peptide in 13 mmol / L tris(hydroxymethylaminomethane) buffer to prepare an osteogenic growth peptide solution with a concentration of 13 ng / mL.

[0064] In the step (1), the diameter of the titanium dioxide nanotube A is 20-25 nm and the length is 5-10 μm.

[0065] Osteogenic Growth Peptide, CAS No.: 132996-61-3. Curcumin, CAS No.: 458-37-7.

[0066] Comparative Example 2 A composition containing titanium dioxide nanotubes, the composition comprising modified titanium dioxide nanotubes A and modified titanium dioxide nanotubes B in a mass ratio of 5:1; The preparation method of the modified titanium dioxide nanotube A comprises the following steps: (1) immersing 1 part by weight of titanium dioxide nanotube A in 11 parts by weight of dopamine hydrochloride solution, reacting at 27° C. for 18 h, filtering, washing with water 4 times, and drying at 27° C. to obtain polydopamine-modified titanium dioxide nanotubes; (2) Immerse 1 part by mass of polydopamine-modified titanium dioxide nanotubes in 7 parts by mass of osteogenic growth peptide solution, react at 27° C. for 18 h, filter, wash 4 times with phosphate buffer solution, and dry at 27° C. to obtain modified titanium dioxide nanotubes A.

[0067] The preparation method of the modified titanium dioxide nanotube B comprises the following steps: (a) Cyclodextrin, water and titanium dioxide nanotubes B in a mass ratio of 0.4:7:1 were mixed and immersed at 54° C. for 90 min to obtain a mixture; (b) A mixture with a mass ratio of 11:1:0.3:0.5, curcumin, aloe-emodin and cassia bark were mixed, sonicated, filtered and dried to obtain modified titanium dioxide nanotubes B.

[0068] The cyclodextrin in step (a) is β-cyclodextrin.

[0069] The mixing conditions in step (b) are stirring at 300 rpm for 70 min, the drying method is drying in a rotary kiln, the rotary kiln has a diameter of 200 mm, an effective working length of 2000 mm, a drying temperature of 180° C., and an inert gas flow rate of 7 L / min; the ultrasonic conditions are: 22 kHz ultrasonic wave for 90 min.

[0070] In the step (a), the titanium dioxide nanotubes B have a diameter of 10-15 nm and a length of 1-5 μm.

[0071] The preparation method of the dopamine hydrochloride solution in step (1) is as follows: dissolving dopamine hydrochloride in 9 mmol / L tris(hydroxymethyl)aminomethane buffer to obtain a dopamine hydrochloride solution with a concentration of 2 mg / mL.

[0072] In the step (1), the pH of the dopamine hydrochloride solution is adjusted to 8.5.

[0073] The preparation method of the osteogenic growth peptide solution in step (2) is: dissolving the osteogenic growth peptide in 13 mmol / L tris(hydroxymethylaminomethane) buffer to prepare an osteogenic growth peptide solution with a concentration of 13 ng / mL.

[0074] In the step (1), the diameter of the titanium dioxide nanotube A is 20-25 nm and the length is 5-10 μm.

[0075] Osteogenic Growth Peptide, CAS No.: 132996-61-3. Curcumin, CAS No.: 458-37-7.

[0076] Comparative Example 3 The difference between this comparative example and Example 1 is that only modified titanium dioxide nanotubes A are included.

[0077] A method for preparing modified titanium dioxide nanotubes A comprises the following steps: (1) immersing 1 part by weight of titanium dioxide nanotube A in 11 parts by weight of dopamine hydrochloride solution, reacting at 27° C. for 18 h, filtering, washing with water 4 times, and drying at 27° C. to obtain polydopamine-modified titanium dioxide nanotubes; (2) Immerse 1 part by mass of polydopamine-modified titanium dioxide nanotubes in 7 parts by mass of osteogenic growth peptide solution, react at 27° C. for 18 h, filter, wash 4 times with phosphate buffer solution, and dry at 27° C. to obtain modified titanium dioxide nanotubes A.

[0078] The preparation method of the dopamine hydrochloride solution in step (1) is as follows: dissolving dopamine hydrochloride in 9 mmol / L tris(hydroxymethyl)aminomethane buffer to obtain a dopamine hydrochloride solution with a concentration of 2 mg / mL.

[0079] In the step (1), the pH of the dopamine hydrochloride solution is adjusted to 8.5.

[0080] The preparation method of the osteogenic growth peptide solution in step (2) is: dissolving the osteogenic growth peptide in 13 mmol / L tris(hydroxymethylaminomethane) buffer to prepare an osteogenic growth peptide solution with a concentration of 13 ng / mL.

[0081] In the step (1), the diameter of the titanium dioxide nanotube A is 20-25 nm and the length is 5-10 μm.

[0082] Osteogenic Growth Peptide, CAS No.: 132996-61-3.

[0083] Comparative Example 4 The difference between this comparative example and Example 1 is that only modified titanium dioxide nanotubes B are included.

[0084] A method for preparing modified titanium dioxide nanotubes B comprises the following steps: (a) Cyclodextrin, water and titanium dioxide nanotubes B in a mass ratio of 0.4:7:1 were mixed and immersed at 54° C. for 90 min to obtain a mixture; (b) A mixture with a mass ratio of 11:1:0.3:0.5, curcumin, aloe-emodin and cassia bark were mixed, sonicated, filtered and dried to obtain modified titanium dioxide nanotubes B.

[0085] The cyclodextrin in step (a) is β-cyclodextrin.

[0086] The mixing conditions in step (b) are stirring at 300 rpm for 70 min, the drying method is drying in a rotary kiln, the rotary kiln has a diameter of 200 mm, an effective working length of 2000 mm, a drying temperature of 180° C., and an inert gas flow rate of 7 L / min; the ultrasonic conditions are: 22 kHz ultrasonic wave for 90 min.

[0087] In the step (a), the titanium dioxide nanotubes B have a diameter of 10-15 nm and a length of 1-5 μm.

[0088] Curcumin, CAS No.: 458-37-7.

[0089] Performance Testing 1. Osteoblasts from the skull of newborn rats were inoculated on the surface of the products of Examples 1-3 and Comparative Examples 1-4 at a density of 1×10 4 / cm 2 , cultured in high-glucose DMEM medium containing 10% fetal bovine serum, and the medium was changed every 2 days. After 7 days of culture, the cells were fixed with 2% glutaraldehyde for 20 min at 4°C; washed with PBS 3 times, 5 min each time; stained with 40mM Alizarin Red for 20 min; washed with distilled water 3 times; added 400μL, 10% (v / v) acetic acid solution, shaken to mix, and incubated for 30min; collected the cells and transferred them to a centrifuge tube, shaken for 30 s to mix evenly; heated at 85°C for 10 min; centrifuged for 15 min, and 200μL of the supernatant was transferred to a new centrifuge tube; ammonium hydroxide (200μL10%) was added to neutralize the acid; the absorbance of the supernatant was detected by an enzyme marker at a wavelength of 405 nm to calculate the standardized mineralization content.

[0090] Table 1 Test results

[0091] The results show that the mineralization content expressed by the cells grown on the compositions prepared in Examples 1-3 is the highest, indicating that the titanium dioxide nanotubes modified with osteogenic growth peptide promote the late differentiation of osteoblasts. However, when the composition of the composition is changed, the effect decreases to varying degrees.

[0092] 2. Antibacterial ability test: Add 1 mL of 10 6 cfu / ml of bacterial solution, and then 1 mg of the products obtained in Examples 1-3 and Comparative Examples 1-4 were added, and cultured at 37°C for 24 hours. After the culture reached the time point, the culture medium was collected and diluted by multiple ratios, the dilution multiple was 10 times, and the number of viable bacteria was detected by the coating culture method, and the sterilization rate was calculated.

[0093] Table 2 Sterilization rate test results

[0094] It can be seen from experiments that the composition prepared by the present invention has a good sterilization rate.

[0095] The above is a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A composition containing titanium dioxide nanotubes, characterized in that: The composition comprises modified titanium dioxide nanotubes A and modified titanium dioxide nanotubes B in a mass ratio of 2-3:1; The preparation method of the modified titanium dioxide nanotube A comprises the following steps: (1) immersing 1 part by weight of titanium dioxide nanotube A in 10-12 parts by weight of dopamine hydrochloride solution, reacting at 20-40° C. for 10-30 hours, filtering, washing with water for 3-5 times, and drying at 25-40° C. to obtain polydopamine-modified titanium dioxide nanotubes; (2) immersing 1 part by weight of polydopamine-modified titanium dioxide nanotubes in 6-8 parts by weight of osteogenic growth peptide solution, reacting at 20-40° C. for 10-30 hours, filtering, washing with phosphate buffer solution for 3-5 times, and drying at 25-40° C. to obtain modified titanium dioxide nanotubes A; The preparation method of the modified titanium dioxide nanotube B comprises the following steps: (a) mixing cyclodextrin, water and titanium dioxide nanotubes B in a mass ratio of 0.2-0.5:5-8:1, and soaking at 52-55° C. for 80-100 min to obtain a mixture; (b) The mixture with a mass ratio of 10-12:1:0.3:0.5, curcumin, aloe-emodin and cassia bark were mixed, sonicated, filtered and dried to obtain modified titanium dioxide nanotubes B.

2. The composition containing titanium dioxide nanotubes according to claim 1, characterized in that: The cyclodextrin in step (a) is β-cyclodextrin.

3. The composition containing titanium dioxide nanotubes according to claim 2, characterized in that: The mixing conditions in step (b) are stirring at 200-500 rpm for 30-100 min, the drying method is drying in a rotary kiln, the rotary kiln has a diameter of 100-300 mm, an effective working length of 1000-2000 mm, a drying temperature of 150° C.-200° C., and an inert gas flow rate of 5-8 L / min; the ultrasonic conditions are: 20-25 kHz ultrasonic wave for 80-100 min.

4. The composition containing titanium dioxide nanotubes according to claim 1, characterized in that: In the step (a), the titanium dioxide nanotubes B have a diameter of 10-15 nm and a length of 1-5 μm.

5. The composition containing titanium dioxide nanotubes according to claim 1, characterized in that: The preparation method of the dopamine hydrochloride solution in step (1) is: dissolving dopamine hydrochloride in 8-10 mmol / L tris(hydroxymethyl)aminomethane buffer to prepare a dopamine hydrochloride solution with a concentration of 1-3 mg / mL.

6. The composition containing titanium dioxide nanotubes according to claim 5, characterized in that: In the step (1), the pH of the dopamine hydrochloride solution is adjusted to 8.

5.

7. The composition containing titanium dioxide nanotubes according to claim 1, characterized in that: The preparation method of the osteogenic growth peptide solution in step (2) is: dissolving the osteogenic growth peptide in 11-14 mmol / L tris(hydroxymethyl)aminomethane buffer to prepare an osteogenic growth peptide solution with a concentration of 12-14 ng / mL.

8. The composition containing titanium dioxide nanotubes according to claim 1, characterized in that: In the step (1), the diameter of the titanium dioxide nanotube A is 20-25 nm and the length is 5-10 μm.

9. Use of the composition containing titanium dioxide nanotubes according to any one of claims 1 to 9 in the preparation of a product for promoting osteoblast maturation.

10. The use according to claim 9, characterized in that: Application of the composition containing titanium dioxide nanotubes in the preparation of medical titanium materials.